Nektar Therapeutics (NKTR) PT Raised to $95 at Wedbush
Tweet
Share
E-mail
Get Alerts NKTR Hot Sheet
Price: $65.72 +7.77%
Rating Summary:
20 Buy, 7 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 10 | New: 23
Rating Summary:
20 Buy, 7 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 10 | New: 23
Join SI Premium – FREE
Wedbush analyst Martin Fan raised the price target on Nektar Therapeutics (NASDAQ: NKTR) to $95.00 (from $70.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Definium Therapeutics Inc (DFTX) PT Raised to $60 at Oppenheimer
- EU approves Arrowhead's plozasiran for rare triglyceride disorder
- Apple investigating exposure to Tata Electronics data breach, full analysis underway - Reuters
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
